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PerceptionAbstract Objective: The purpose of this study is to identify the community pharmacist percep-
tions and attitudes toward ethical issues at community pharmacy setting in Saudi Arabia.
Method: Across-sectional, descriptive, and qualitative survey of community pharmacists was con-
ducted and the survey questions were pre-tested by a pharmacist with extensive experience in ethical
issues. Based on the result of a pilot study the questionnaire was used with somemodiﬁcations and the
ﬁnal questionnaire was sent to the participants by handing over in person, mail or Email.
Results: 45.7% Often discuss ethical issues with their patients, while only 2.1% never discuss it.
40.6% often record the ethical concern whereas only 1.9% of them never do so. 31.5% reported that
patients initiate ethical issues.
Discussion: 28.3% of the pharmacists initiate the discussion. The barriers that limit discussing eth-
ical issues with their patients were lack of time due to other obligations assigned to the community
pharmacist (69.2%), lack of reliable resources (10.7%), not interested in the subject (10.1%), lack
of knowledge on ethical issues (4.8%), and other reasons (5.3%). Recourses are books (37.7%), inter-
net web sites (31.1%), and brochures (26.8%). Only aminority of respondents had access to computer
databases (15.8%) and other resources (1.3%).Most perceived ethical problemswere: being asked for
hormonal contraception, dispensing a drug for unreported indication (69.2%), dispensing dose of
medicine for a child that is outside the SNF limits (68.9%), unwantedprofessional behavior about con-
trolled drugs (66.6%), a colleague insisting on unethical behavior (65.0%), a colleague has done some-
thingunethical for the ﬁrst time (64.7%), suspecting that a child is being abused (63.3%)prescribing on
private scripts for suspectedmedications of possible abuse (60.7%) and terminally ill patient asks for a
diagnosis or prognosis (52.9%).
316 M.N. Al-AriﬁConclusion: The ﬁndings of this study assured the need of Saudi health authorities to implement
a code of ethics for pharmacy practicing to cover all aspects of ethical issues.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The importance of ethical issues in pharmacy practice high-
lights the necessity of considering ethical principles by pharma-
cists. Ethics of medical practice dates back to the ancient
civilizations, as we see from the Hippocratic Oath (Sauer,
1985). Recent times have witnessed a dramatic raise regarding
ethical issues in the health care sector, particularly issues that
concern prioritizing health care and moral decision making
(Bennci, 1991). Ethical concerns in health care have grown
mainly because of the increasing cost concerns and technolog-
ical developments in pharmacy practice. Community phar-
macy practice encountered many ethical conﬂicts because of
the commercial nature of pharmacy. Moreover, the consumer-
ist nature of community pharmacy and the co-modiﬁcation of
medicines have led to experiencing a number of conﬂicts (Hib-
bert et al., 1999).
In Saudi Arabia, the development of the health care system
began in 1925 when a public health department was estab-
lished. In 1951 ministry of health was established, since then
the health services have expanded immensely from 1970 to
1980 (Alkabba et al., 2012). In addition to medicines’ dispens-
ing, the most important service provided by pharmacists in
Saudi Arabia is answering a wide range of queries of patients.
Therefore, the pharmacists need to be well-oriented with ethi-
cal issues and the way of implementing the best ethical solution
at critical conditions (Sharif et al., 2011). Being members of
society and healthcare team, community pharmacists go about
their lives and work undertaking activities that may lead to
questions as to whether what they do is appropriate, right, just
or legal. It is also possible to think of ethical matters in com-
munity pharmacy from the perspective of the pharmacists and
to reﬂect upon what ethical issues might mean to them (Coo-
per, 2006).
Community pharmacists are ‘front line’ health care profes-
sionals and are involved in dispensing life-saving medication
and giving health advice about medicines and the treatment
of minor ailments to members of the public. Community phar-
macists often run a commercial business alongside their health-
care service which may encounter dramatic dilemmas (Brazier
Margaret, 2005). In Saudi Arabia, the possibility of ethical is-
sues is increasing due to the corporate ownership of pharma-
cies (Blenkinsopp et al., 1999) which may mean that
pharmacists encounter new ethical concerns as more become
employees in large organizations. Such changes offer not only
the possibility of ethical assistance from an organization and
its employees (de George, 1990) but also the potential chal-
lenges of a different culture (Trevino, 1986) and organizational
climate (Sims and Keon, 1997).
In contrast to medicine and nursing, relatively little re-
search has considered ethics in pharmacy and particularly
community pharmacy (Cooper et al., 2006). Pharmacy practice
has received little attention from practical ethics, in spite of
extensive research into other areas of health care. A recent
study that investigated an extensive literature search of phar-macy ethics found that there is little research literature specif-
ically addressing ethics in pharmacy practice and almost none
addressing fundamental values for pharmacy ethics (Wingﬁeld
and Anderson, 2004). Much of the research that does set out to
address ethics in pharmacy is concerned with speciﬁc issues
such as conﬁdentiality (Auguste et al., 1997; Wills et al.,
2002), the supply of emergency hormonal contraception (Bis-
sell et al., 2001; Bissell and Anderson, 2003; Seston et al.,
2002) and ethical decision-making (Cooper et al., 2009), rather
than surveying ethical views. In Saudi Arabia, most of such
types of studies focus on the Islamic perspective of some clin-
ical practices such as organ donation (Albar, 1996; Ebrahim,
1995), and end-of-life issues (Babgi, 2009; Mobeireek, 1995)
or other issues like patient satisfaction (Mansour and Al-Osi-
my, 1993). After thorough searching of databases, there are
no published studies addressing ethical issues in community
pharmacy practice in Saudi Arabia. Therefore, the purpose
of this study is to identify the community pharmacist percep-
tions and attitudes toward ethical issues at community phar-
macy setting in Saudi Arabia.2. Methodology
A cross-sectional, descriptive, and qualitative survey of com-
munity pharmacists in the Riyadh region, Saudi Arabia was
conducted. The data were collected from July to December
2012 using a structured self-administered questionnaire. The
questionnaire was designed and developed from review of
the literature and previous studies relating to the ethical issues
in community pharmacy (Deans, 2008). The survey questions
were pre-tested by a pharmacist with extensive experience in
ethical issues. A draft of the questionnaire was piloted on
the convenience of practicing pharmacists to check for read-
ability, understanding, question design and the length of the
questionnaire. Based on the result of this pilot study the ques-
tionnaire was used with some modiﬁcations and the ﬁnal ques-
tionnaire was sent to the participants by handing over in
person, mail or E-mail.
The survey questionnaire consisted of a brief introduction
of the study and thirty-two questions. The questions consisted
of closed ended, multiple-choice, ﬁll-in short answers and
statements (dilemmas). The questionnaire was constructed to
include three sections. The ﬁrst section compiled demographic
information and closed-ended questions about whether they
received previous continuing education on ethics in pharmacy
practice, or have been accessed for ethical information at prac-
tice site. The second section asked about the frequency with
which ethical issues are discussed with patients, and whether
they discuss ethical issues and how often this information
was documented in the pharmacy records, what are the barri-
ers that limit pharmacists from explaining ethical issues to
their patients, which ethical information resources are cur-
rently available at practice sites, and what perceived resources
that would be helpful in caring the patients. The third section
Table 1 Demography and some characteristics of the respondent pharmacists.
Characteristics Frequency (%)
Age N= 682
25–35 years 529 (77.6%)
36–45 years 96 (14.1%)
46–55 years 27 (4.0%)
56 and above 4 (6%)
Mean 33.87 (range 25–60 years)
Have you ever received any previous continuing education on ethics on practicing pharmacy services? N= 682
Yes 491 (72.3%)
No 189 (27.7%)
Have you ever been accessed for ethical information at practice site? N= 682
Yes 442 (64.8%)
No 230 (33.7%0
How often do you discuss ethical issues with your patients? N= 682
Never 14 (2.1%)
Rarely 69 (10.1%)
Some times 190 (27.9%)
Often 312 (45.7%)
Very often 97 (14.2%)
If you discuss ethical issues with your patients, the discussion is:- N= 682
Self-initiated 193 (28.3%)
Patient-initiated conversation 215 (31.5%)
One-time discussion 93 (13.6%)
Ongoing discussion 93 (13.6%)
How often do you record ethical concerns in your pharmacy? N= 682
Very often 101 (14.8%)
Often 277 (40.6%)
Some times 173 (25.4%)
Rarely 76(11.1%)
Never 13 (1.9%)
What are the barriers that limit you from explaining ethical issues with your patients? N= 682
Lack of time 472 (69.2%)
Lack of reliable resources 73 (10.7%)
Not interested in subject 69 (10.1%)
Lack of ethical knowledge 33 (4.8%)
Others 36 (5.3%)
Which ethical reference is readily available in your pharmacy (if any)? N= 682
Books 257 (37.7%)
Brochures 183 (26.8%)
Internet web sites 212 (31.1%)
Computer databases 108 (15.8%)
Others 9 (1.3%)
Which of the following ethical resources would be helpful in caring for your patients (check all that applies)? N= 682
Books 223 (32.7%)
Brochures 186 (27.3%)
Internet web sites 259 (38.0%)
Computer databases 113 (16.6%)
Consultation services by pharmacist 22 (3.2%)
Others 23 (3.4%)
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dilemma faced by community pharmacist. On a scale of one to
seven (1 = do not know, 2 = never, 3 = hardly ever
4 = every few months 5 = once or twice a month 6 = once
or twice a week 7 = at least once a day), the respondents were
asked to rank their perceptions regarding the extent to which
they considered the various issues to be of ethical importance
in their community settings (Table 3). The purpose of these
questions was to ﬁnd out how often certain problems occurredin pharmacy practice and how pharmacists dealt with these
problems or, if they had not encountered such problems,
how they thought they would deal with them. Responses were
considered positive when the respondent answered every few
months, once or twice a month, once or twice a week, or at
least once daily. For the purpose of correlation between the
respondents’ experience and their views, the study respondents
were categorized into two age groups (25–35 and >35 years
old). Notably, gender is not included in the demographics as
318 M.N. Al-Ariﬁfemale pharmacists are not allowed to work in community
pharmacy in Saudi Arabia.
A stratiﬁed random sample of eight hundred ﬁfty registered
pharmacy practitioners all over the Riyadh region, Saudi Ara-
bia were randomly chosen to respond to the survey. Commu-
nity pharmacies in the Riyadh region were randomly selected
for visits according to their geographical distribution (i.e.,
north, south, east, and west). The selection of facilities was
done at random with a clear intention to include different
areas of the Riyadh region. The questionnaire was followed
up for collection on a later date that ranged from one to seven
weeks. Non-respondents were telephoned, emailed or visited to
return their questionnaire. All returned usable questionnaires
were completed anonymously.
The data from each of the returned questionnaire were
coded and entered into Statistical Package for the Social Sci-
ences (SPSS) version 19 software (SPSS Inc., Chicago, IL,
USA) which was used for statistical analysis. Descriptive sta-
tistics include percentages; means and frequency distribution
were calculated for each of the scenarios. Chi square test was
used to ﬁnd the correlation between qualitative variables at
the 5% signiﬁcance level. A p-value of <0.05 represents a sig-
niﬁcant difference.
3. Results
A total of 850 questionnaires were distributed to randomly se-
lected community pharmacists but only 682 pharmacists re-
sponded to the survey with completely answered
questionnaire with a response rate of 80.2%. The demographic
characteristics of the respondents are summarized in Table 1.Table 2 Comparison between some views of respondent pharmacis
Some characteristics’ of respondents pharmacists Age group
25–35 years
n (%)
Have you ever received any previous continuing
education on ethics on practicing pharmacy
services?
Yes 390 (73.9%)
No 138 (26.1%)
Have you ever been accessed to ethics information
at practice site?
Yes 348 (66.5%)
No 175 (33.5%)
How often do you discuss ethical issues with your
patients?
Never 7 (1.3%)
Rarely 60 (11.3%)
Sometimes 150 (28.4%)
Often 236 (44.6%)
Very often 76 (14.4%)
How often do you record ethical concerns in your
pharmacy?
Never 62 (11.9%)
Rarely 142 (27.3%)
Sometimes 209 (40.2%)
Often 77 (14.8%)
Very often 30 (5.8%)The mean age of the respondents was 33.87 years (range 25–
60 years). Majority of survey respondents (72.3%) received
previous continuing education on ethics on practicing phar-
macy services and 27.7% were not well in this regard. About
sixty-ﬁve percent (64.8%) of the participated pharmacists were
accessed for ethical information at their practice site.
The study results show that 45.7% of the participants often
discuss ethical issues with their patients, while only 2.1% never
discus it. Study shows 40.6% of participated pharmacists often
record the ethical concern whereas only 1.9% of them never do
so. However, with regard to initiation of the discussion, the
study shows that 31.5% of the respondents reported that pa-
tients initiate the ethical issue discussion while 28.3% reported
that the pharmacists initiate the discussion. This discussion
was reported to be a one time discussion by 13.6% of the
respondents and ongoing discussion by the same percentage.
According to the study results, respondents reported that the
most common barriers that limit discussing ethical issues with
their patients were lack of time due to other obligations as-
signed to the community pharmacist (69.2%), lack of reliable
resources (10.7%), not interested in the subject (10.1%), lack
of knowledge on ethical issues (4.8%), and other reasons
(5.3%).
Pharmacists who discussed ethical concern with their pa-
tients rely on various resources to answer inquiries and gather
information pertaining to ethical issues. Reliable ethical refer-
ence currently available to the respondent pharmacists at their
practice sites is illustrated in Table 1. The ﬁndings in this study
indicated that community pharmacists turn most greatly to
books (37.7%) to ﬁnd information on ethical issues followed
by internet web sites (31.1%) and brochures (26.8%). Only ats according to their age groups.
p-Value
Above 35 years
n (%)
Total n (%)
84 (66.7%) 474 (72.5%) .066
42 (33.3%) 180 (27.5%)
78 (61.9%) 426 (65.6%) .189
48 (38.1%) 223 (34.4%)
5 (3.9%) 12 (1.8%)
6 (4.7%) 66 (10.1%) .073
36 (28.3%) 186 (28.4%)
61 (48%) 297 (45.3%)
19 (15%) 95 (14.5%)
11 (8.9%) 73 (11.4%)
27 (22%) 169 (26.3%) .418
54 (43.9%) 263 (40.9%)
20 (16.3%) 97 (15.1%)
11 (8.9%) 41 (6.4%)
Table 3 Different scenarios used in the third section in the survey.
1. A customer asks for an over-the-counter treatment. After talking to the patient you come to the conclusion that s/he does not really need the
treatment, thought it would do no harm for him/her to use it
2. The prescription states a speciﬁc brand of drug. You do not have this in stock but you have a generic clinically equivalent brand in stock
3. A patient comes in for his/her controlled drug prescription but it is the day after the date speciﬁed on the prescription
4. After questioning, a patient makes it known s/he is going to use the medication she/he is asking to buy against guidelines (e.g. hydrocortisone
cream for his/her face)
5. A customer wants to buy an over-the-counter medicine you suspect s/he might be abusing (may be this appears likely after speaking to him/
her about it) and the customer does not want an alternative
6. The husband or wife, or another close family member (other than the parent of a child) of a patient asks for conﬁdential information about
that patient’s treatment
7. Someone comes into the pharmacy/phones you asking you to identify a particular tablet that does not belong to him/her. You are able to
identify the tablet
8. You believe that withholding the truth from, or deliberately misleading, a patient would mean s/he would be compliant with a treatment you
believe is very important to him/her
9. A female comes in and asks for hormonal contraception. She says she is married, but you suspect she is not
10. You feel something a colleague has done is unethical
11. You feel something a colleague has done is unethical and you talk to your colleague, but still s/he does not change his/her behavior
12. A parent of a patient asks for conﬁdential information about his/her son/daughter’s treatment
13. A doctor is prescribing, on private scripts, medication you suspect s/he is abusing. You’ve already talked to him/her about it but s/he has
clearly ignored you.
14. You Suspect a child, who is one of your patients, may be subject to abuse at home
15. You suspect a pharmacist you work with is using prescription medicine from the controlled drugs cabinet without a prescription. You
already talked to him/her about it but s/he clearly ignored you
16. A pediatric consultant has asked you to dispense, for a child, a dose of medicine that is outside the Saudi national formulary limits, but is still
not at toxic level. You speak with the consultant about it who conﬁrms these are his/her wishes
17. A consultant asks you to dispense a drug for an unreported indication and tells you s/he knows it is used for this indication with great eﬀect
in USA
18. A member of the public comes to the pharmacy and asks for some medication for someone else who is waiting at home (e.g. his wife, who is
in great distress). S/he tells you that the person for whom the medication is for has used the medicine several times before and is very familiar
with it for example digoxin
19. A terminally ill patient asks you for a diagnosis or prognosis, telling you s/he does not feel the doctor is telling the whole truth. You know
the full case history
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(15.8%) and other resources (1.3%).
Generally, when respondents were asked about their favor-
ite resource format that would be helpful in answering ques-
tions and caring for their patients about ethical issues,
majority of the pharmacists surveyed perceived web sites
(38.0%) and books (32.7%) (Table 1). These were followed
by brochures (27.3%) and computer databases (16.6%), while
others preferred consultation services (3.2%) and others
(3.4%). There was no signiﬁcant difference between the two
age groups with regard to their views toward the continuous
ethical education, being accessed for ethical information, the
frequency of discussing ethical issues with patients and the
documentation of these ethical concerns as shown in Table 2.
Table 4 details the frequency of occurrence of speciﬁc eth-
ical problems. In response to the survey scenarios, results show
that the most perceived ethical problems were being asked for
hormonal contraception over the counter and dispensing a
drug for unreported indication (69.2%), dispensing dose of
medicine for a child that is outside the Saudi national formu-
lary (SNF) limits (68.9%), unwanted professional behavior
about controlled drugs (66.6%), a colleague insisting on uneth-
ical behavior (65.0%), a colleague has done something uneth-
ical for the ﬁrst time (64.7%), suspecting that a child is being
abused (63.3%) prescribing on private scripts for suspected
medications of possible abuse (60.7%) and terminally ill pa-
tient asks for a diagnosis or prognosis (52.9%). The remainingscenarios were with less than 50% of total positive response as
shown in Table 4.
Table 5 shows the difference between the views of the two
age groups in relation to different ethical scenarios. The
respondents’ views showed a signiﬁcant difference between
younger and older pharmacists in 5 out of 19 proposed ethical
dilemmas (p< 0.05). Table 6 shows the association between
different ethical dilemmas and previous continuing education
on ethics in pharmacy practice. The respondents’ views showed
a signiﬁcant difference between those who had exposure to
continuous education on ethics and those who had not in 5
out of 19 proposed ethical dilemmas (p< 0.05).
Table 7 shows the association between different ethical
dilemmas and access to ethical information resources at their
practice site. The respondents’ views showed a signiﬁcant dif-
ference between those who had access to ethical information
resources and those who did not in 8 out of 19 proposed eth-
ical dilemmas (p< 0.05).4. Discussion
The presence of a centralized healthcare system in a culturally
diverse population in Saudi Arabia may give rise to a set of
ethical issues. Therefore the ﬁndings of this study is impor-
tant for providing evidence that ethical problem-solving is
an important part of the ‘job description’ of pharmacists
Table 4 The Frequency of occurrence of speciﬁc ethical problems.
Statements Diﬀerent ethical dilemmas and their values indicating the frequency and percentages (%) Total positive
response n/(%)
Do not know
frequency (%)
Never
frequency (%)
Hardly ever frequency (%) Every few months
frequency (%)
Once or twice
a month frequency (%)
Once or twice
a week frequency (%)
At least once
a day frequency (%)
Q1 113 (16.6%) 170 (24.9%) 101 (14.8%) 90 (13.2%) 80 (11.7%) 66 (9.7%) 57 (8.4%) 293 (43%)
Q2 190 (27.9%) 142 (20.8%) 127 (18.6%) 69 (10.1%) 42 (6.2%) 48 (7.0%) 52 (7.6%) 211 (30.9%)
Q3 68 (10%) 146 (21.4%) 92 (13.5%) 64 (9.4%) 100 (14.7%) 141 (20.7%) 53 (7.8%) 358 (52.5%)
Q4 86 (12.6%) 137 (20.1%) 169 (24.8%) 88 (12.9%) 78 (11.4%) 64 (9.4%) 45 (6.6%) 275 (40.3%)
Q5 88 (12.9%) 139 (20.4%) 140 (20.5%) 106 (15.5%) 95 (13.9%) 64 (9.4%) 48 (7.0%) 313 (45.9%)
Q6 88 (12.9%) 132 (19.4%) 134 (19.6%) 94 (13.8%) 118 (17.3%) 78 (11.4%) 34 (5.0%) 324 (47.5%)
Q7 106 (15.5%) 144 (21.1%) 145 (21.3%) 97 (14.2%) 81 (11.9%) 59 (8.7%) 39 (5.7%) 276 (40.5%)
Q8 71 (10.4%) 117 (17.2%) 177 (26.0%) 101 (14.8%) 72 (10.6%) 63 (9.2%) 65 (9.5%) 301 (44.1%)
Q9 25 (3.7%) 80 (11.7%) 100 (14.7%) 95 (13.9%) 150 (22%) 185 (27.1%) 42 (6.2%) 472 (69.2%)
Q10 38 (5.6%) 89 (13.0%) 98 (14.4%) 94 (13.8%) 128 (18.8%) 166 (24.3%) 53 (7.8%) 441 (64.7%)
Q11 46 (6.7%) 91 (13.3%) 90 (13.2%) 80 (11.7) 122 (17.9%) 191 (28%) 50 (7.3%) 443 (65%)
Q12 134 (19.6%) 137 (20.1%) 134 (19.6%) 116 (17.0%) 72 (10.6%) 67 (9.8%) 17 (2.5%) 272 (39.9%)
Q13 52 (7.6%) 95 (13.9%) 116 (17.0%) 112 (17.9%) 136 (19.9%) 117 (17.2%) 39 (5.7) 414 (60.7%)
Q14 32 (4.7%) 88 (12.9%) 112 (16.4%) 117 (17.2%) 126 (18.5%) 144 (21.1%) 45 (6.6%) 432 (63.3%)
Q15 35 (5.1%) 104 (15.2%) 79 (11.6%) 102 (15%) 88 (12.9%) 221 (32.4%) 43 (6.3%) 454 (66.6%)
Q16 28 (4.1%) 86 (12.6%) 87 (12.8%) 145 (21.3%) 146 (21.4%) 144 (21.1%) 35 (5.1%) 470 (68.9%)
Q17 28 (4.1%) 81 (11.9%) 88 (12.9%) 113 (16.6%) 11.3 (16.6%) 196 (28.7%) 50 (7.3%) 472 (69.2%)
Q18 119 (17.4%) 116 (17%) 143 (21%) 98 (14.4%) 77 (11.3%) 73 (10.7%) 48 (7%) 296 (43.4%)
Q19 70 (10.3%) 107 (15.7%) 136 (19.9%) 134 (19.6%) 93 (13.6%) 79 (11.6%) 55 (8.1%) 361 (52.9%)
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Table 5 The difference between positive responses of the two age groups in relation to various ethical statements.
Statements Age group p-Value
25–35 years n (%) Above 35 years n (%) Total n (%)
Q1 219 (41.8%) 70 (55.1%) 289 (44.4%) .005
Q2 168 (32.3%) 39 (31.2%) 207 (32.1%) .451
Q3 290 (56.4%) 56 (45.2%) 346 (54.2%) .016
Q4 226 (43.8%) 39 (31.0%) 265 (41.3%) .005
Q5 249 (47.2%) 56 (44.4%) 305 (46.6%) .327
Q6 254 (48.4%) 59 (46.5%) 313 (48%) .386
Q7 219 (42%) 49 (39.2%) 268 (41.5%) .318
Q8 228 (44.1%) 57 (46.3%) 285 (44.5%) .363
Q9 356 (67.8%) 94 (74.6%) 450 (69.1%) .083
Q10 337 (65.2%) 84 (67.7%) 421 (65.7%) .334
Q11 334 (64.5%) 88 (69.8%) 422 (65.5%) .151
Q12 220 (41.9%) 39 (31%) 259 (39.8%) .015
Q13 321 (61%) 74 (59.2%) 395 (60.7%) .391
Q14 331 (64.1%) 83 (67.5%) 414 (64.8%) .279
Q15 350 (66.9%) 82 (66.1%) 432 (66.8%) .472
Q16 360 (68.8%) 89 (72.4%) 449 (69.5%) .258
Q17 350 (66.9%) 97 (77.6%) 447 (69.5%) .017
Q18 233 (44.6%) 49 (39.2%) 282 (43.5%) .163
Q19 272 (52%) 73 (58.4%) 345 (53.2%) .117
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in the health care system (Deans, 2008). The study revealed a
set of barriers that limit pharmacists from discussing ethical
issues with their patients. The most important of these barri-
ers are lack of time, lack of reliable resources, and lack of
knowledge on ethical issues. These ﬁndings reinforced the
ﬁndings of similar studies (Rogers, 2004) that identiﬁed lack
of time and multiple pressures were the important barriers
that limit pharmacists from discussing ethical issues with their
patients.
Although a part of the problem lies in the accessibility of
resources and knowledge, community pharmacists also need
education and ofﬁcial training on ethics and where to ﬁnd eth-
ics information and how to evaluate it to make an appropriate
decision before making a recommendation and providing
information for their patients. Several pharmacists commented
that continuing education programs would be helpful in
increasing their knowledge base in pharmacy ethics. Likewise,
an overwhelming number of pharmacists and physicians agree
that education and training programs on ethics are useful for
all medical staff. However several studies stated that role-mod-
eling is used in medical teaching as a useful method of educa-
tion in both ethical and clinical aspects (Weissman et al., 2006).
Previous studies determined that information disclosure is
the most important ethical problem that faces community
pharmacists (Vitell et al., 1991). A considerable percentage
of respondents agreed to breach the patients’ conﬁdentiality
as in the case of scenario number 7 (47.5%) while only
52.5% disagreed. Whereas another study stated that 92% of
the respondents would not disclose it (Deans, 2008). This
may be due to the lack of knowledge in this respect in Saudi
Arabia. Therefore the necessity of teaching ethics is of great
importance. Supplying enough information to patients by
pharmacists raises several doubts about the type of informa-
tion, the type of provision of information, the amount of infor-
mation and to whom the information should be given whichusually involve ethical issues. It seems necessary to increase
the sensitivity of pharmacists to the consequences of their
practice when disclosing patient’s information.
The accessibility of over-the-counter (OTC) medicines that
can be purchased from community pharmacies is growing
worldwide (Blenkinsopp and Bradley, 1996). It is worth noting
that only 43% of the community pharmacists would sell med-
ication over the counter to a patient who does not really need it
(and who would also not be harmed by it) compared to only
13% in earlier studies (Deans, 2008). This is because the com-
munity pharmacists are under commercial pressure and more
concerned about their own ﬁnancial interests. There is evi-
dence that the supply of OTC is not always appropriate
(Goodburn et al., 1991; Krska et al., 1994; Counter advice,
1999; Mobey et al., 1986; Anonymous, 2004) therefore a
change in community pharmacy practice in Saudi Arabia is
required.
Study results show that regarding opinion on whether to
dispense clinically equivalent medication when the pharmacy
is out of stock of the brand named on the prescription
30.9% would dispense in these conditions which is comparable
to 29% in another study (Deans, 2008). This is because of the
availability of multinational products in Saudi’s medicine mar-
ket which may complicate the problem.
Contraception is a safe and effective method for preventing
pregnancy (Emergency, 2005, 2005) and has the potential to
prevent up to 75% of unplanned pregnancies (Trussell et al.,
1999). Over the matter of a suspected unmarried female
requesting hormonal contraception, opinions were divided
over whether to supply hormonal contraception or not. Major-
ity of the study respondents (69.2%) agreed compared to only
21% in previous study (Deans, 2008). This may be due to the
worldwide misinformation regarding this method of contra-
ception among both consumers and health care professionals
(Chuang and Freund, 2005; Borrego et al., 2006; Wallace
et al., 2004).
Table 6 The Association between various statements and previous continuing education on ethics in pharmacy practice.
Statements - Have you ever received any previous continuing education on ethics on practicing pharmacy services? p-Value
Do not
know yes (%)
Never
yes (%)
Hardly
ever yes (%)
Every few
months yes (%)
Once or twice
a month yes (%)
Once or twice
a week yes (%)
At least once
a day yes (%)
Q1 83 (17%) 139 (28.5%) 77 (15.8%) 57 (11.7%) 49 (10.1%) 43 (8.8%) 39 (8.0%) 0.005
Q2 151 (31.3%) 98 (20.3%) 90 (18.7%) 51 (10.6%) 29 (6.0%) 30 (6.2%) 33 (6.8%) 0.121
Q3 46 (9.6%) 105 (22.0%) 75 (15.7%) 47 (9.8%) 62 (13.0%) 100 (20.9%) 43 (9.0%) 0.045
Q4 61 (12.7%) 99 (20.6%) 124 (25.8%) 68 (14.2%) 54 (11.3%) 44 (9.2%) 30 (6.3%) 0.899
Q5 68 (13.9%) 95 (19.4%) 108 (22.1%) 81 (16.6%) 65 (13.3%) 36 (7.4%) 36 (7.4%) 0.025
Q6 72 (14.8%) 86 (17.6%) 106 (21.7%) 65 (13.3%) 79 (16.2%) 57 (11.7%) 23 (4.7%) 0.050
Q7 75 (15.5%) 109 (22.6%) 111 (23.0%) 71 (14.7%) 52 (10.8%) 41 (8.5%) 24 (5.0%) 0.236
Q8 58 (12.2%) 80 (16.8%) 129 (27.1%) 77 (16.2%) 48 (10.1%) 43 (9.0%) 41 (8.6%) 0.226
Q9 17 (3.5%) 50 (10.3%) 73 (15%) 77 (15.8%) 100 (20.6%) 138 (28.4%) 31 (6.4%) 0.095
Q10 28 (5.9%) 63 (13.2%) 73 (15.3%) 71 (14.9%) 89 (18.6%) 118 (24.7%) 36 (7.5%) 0.924
Q11 34 (7.1%) 61 (12.7%) 69 (14.3%) 61 (12.7%) 87 (18%) 135 (28%) 35 (7.3%) 0.709
Q12 106 (21.8%) 99 (20.3%) 96 (19.7%) 87 (17.9%) 44 (9.0%) 44 (9.0%) 11 (2.3%) 0.161
Q13 43 (8.8%) 66 (13.6%) 90 (18.5%) 93 (19.1%) 89 (18.3%) 82 (16.8%) 24 (4.9%) 0.095
Q14 25 (5.3%) 61 (12.8%) 83 (17.5%) 89 (18.7%) 90 (18.9%) 96 (20.2%) 31 (6.5%) 0.610
Q15 24 (5.0%) 63 (13.0%) 57 (11.8%) 85 (17.6%) 60 (12.4%) 169 (35.0%) 25 (5.2%) 0.003
Q16 18 (3.7%) 64 (13.3%) 64 (13.3%) 113 (23.4%) 101 (20.9%) 101 (20.9%) 22 (4.6%) 0.489
Q17 20 (4.2%) 54 (11.2%) 67 (13.9%) 85 (17.7%) 88 (18.3%) 137 (28.5%) 30 (6.2%) 0.161
Q18 83 (17.1%) 86 (17.7%) 109 (22.4%) 71 (14.6%) 56 (11.5%) 45 (9.3%) 36 (7.4%) 0.398
Q19 62 (12.7%) 71 (14.6%) 111 (22.8%) 105 (21.6%) 56 (11.5%) 47 (9.7%) 35 (7.2%) 0.000
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Table 7 The relationship between various statements and accessing ethical information at practice site.
Statements Have you ever been accessed to ethics information at practice site? p-Value
Do not know
frequency (%)
Never
frequency (%)
Hardly ever
frequency (%)
Every few
months frequency (%)
Once or twice
a month frequency (%)
Once or twice
a week frequency (%)
At least once
a day frequency (%)
Q1 92 (21%) 110 (25.1%) 69 (15.7%) 55 (12.5%) 42 (9.6%) 41 (9.3%) 30 (6.8%) .000
Q2 126 (29%) 90 (20.7%) 84 (19.4%) 43 (9.9%) 33 (7.6%) 29 (6.7%) 29 (6.7%) .287
Q3 41 (9.6%) 102 (23.8%) 63 (14.7%) 46 (10.7%) 66 (15.4%) 86 (20%) 25 (5.8%) .036
Q4 51 (11.8%) 89 (20.6%) 126 (29.1%) 58 (13.4%) 44 (10.2%) 41 (9.5%) 24 (5.5%) .035
Q5 63 (14.3%) 91 (20.6%) 94 (21.3%) 73 (16.6%) 59 (13.4%) 34 (7.7%) 27 (6.1%) .207
Q6 64 (14.5%) 86 (19.5%) 96 (21.8%) 59 (13.4%) 66 (15%) 45 (10.2%) 24 (5.5%) .065
Q7 68 (15.7%) 106 (24.4%) 97 (22.4%) 61 (14.1%) 46 (10.6%) 32 (7.4%) 24 (5.5%) .083
Q8 46 (10.7%) 79 (18.4%) 121 (28.1%) 63 (14.7%) 48 (11.2%) 41 (9.5%) 32 (7.4%) .136
Q9 11 (2.5%) 55 (12.5%) 70 915.9%) 71 (16.2%) 96 (21.9%) 109 (24.8%) 27 (6.2%) .028
Q10 26 (6.1%) 57 (13.3%) 70 (16.4%) 62 (14.5%) 76 (17.8%) 103 (24.1%) 33 (7.7%) .709
Q11 33 (7.7%) 60 (13.9%) 61 (14.2%) 48 (11.1%) 81 (18.8%) 117 (27.1%) 31 (7.2%) .625
Q12 99 (22.6%) 93 (21.2%) 89 (20.3%) 68 (15.5%) 35 (8.0%) 41 (9.4%) 13 (3.0%) .008
Q13 39 (8.9%) 63 (14.4%) 83 (18.9%) 86 (19.6%) 89 (20.3%) 55 (12.6%) 23 (5.3%) .000
Q14 20 (4.7%) 57 (13.3%) 83 (19.4%) 85 (19.9%) 87 (20.4%) 73 (17.1%) 22 (5.2%) .000
Q15 22 (5.2%) 68 (15.6%) 52 (12.0%) 73 (16.8%) 60 (13.8%) 140 (32.2%) 20 (4.6%) .116
Q16 15 (3.4%) 58 (13.3%) 64 (14.7%) 94 (21.6%) 91 (20.9%) 93 (21.4%) 20 (4.6%) .404
Q17 20 (4.6%) 53 (12.3%) 54 (12.5%) 80 (18.5%) 72 (16.7%) 129 (29.9%) 24 (5.6%) .089
Q18 72 (16.5%) 75 (17.2%) 100 (22.9%) 66 (15.1%) 53 912.1%) 39 (8.9%) 32 (7.3%) .221
Q19 50 (11.4%) 78 (17.8%) 96 (21.9%) 96 (21.9%) 47 (10.7%) 42 (9.6%) 29 (6.6%) .000
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324 M.N. Al-Ariﬁ5. Conclusion
The ﬁndings of this study assured the need of Saudi health
authorities to implement a code of ethics for pharmacy
practicing to cover all aspects of ethical issues. Also commu-
nity pharmacists need education and ofﬁcial training on eth-
ics and where to ﬁnd ethics information and how to
evaluate it to make an appropriate decision before making
a recommendation and providing information for their pa-
tients. The broad aims of formal ethics education in voca-
tional subjects tend to raise awareness of ethical issues
and the guidelines of the profession, and to provide a struc-
ture to assessing ethical problems and making appropriate,
justiﬁable decisions.References
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